Wallife and Tomorrow Bio to launch cryopreservation insurance

Wallife, an Italian startup focused on offering insurance products to protect people from new technology risks, has partnered with Tomorrow Bio to introduce the first insurance policy designed for individuals undergoing cryopreservation.

With 600 to 700 people signed up for cryopreservation in Europe, the product aims to offer financial protection for those investing in future medical possibilities. The insurance will be available to European customers in 2025, marking a new step in insuring emerging technological risks.

“In today’s rapidly evolving technological landscape, it’s crucial to build products that address emerging risks. This partnership with Tomorrow Bio underscores our commitment to pushing the boundaries of the insurance industry, providing pioneering solutions where none existed before. Cryopreservation opens up exciting possibilities for the future, and it’s our responsibility to protect those choosing to invest in these groundbreaking medical advances.” – Polina Marenkova, Chief of Innovation Lab at Wallife .

“What we do at Tomorrow Bio is a very long-term mission, we are excited to partner with innovative leaders such as like Wallife to bring it into reality. We’re thrilled to find people and companies who are willing to engage in high impact, long-term thinking – Wallife is a perfect partner in that regard!” – Dr. Emil Kendziorra, Founder & CEO at Tomorrow Bio .